Literature DB >> 16548057

Proteomic analysis of serum marker proteins in recipient mice with liver cirrhosis after bone marrow cell transplantation.

Yuichiro Yokoyama1, Shuji Terai, Tsuyoshi Ishikawa, Koji Aoyama, Yohei Urata, Yoshio Marumoto, Hiroshi Nishina, Kazuyuki Nakamura, Kiwamu Okita, Isao Sakaida.   

Abstract

We previously found that transplantation with bone marrow cells (BMCs) improves liver function and liver fibrosis in cirrhotic mice. In the presence of liver damage induced by carbon tetrachloride (CCl4), transplanted BMC migrated into the peri-portal region and trans-differentiated into hepatocytes that produce albumin. Thus under these conditions, BMC transplantation induces liver regeneration. Detecting serum marker proteins is important to monitor the recovery of liver function of cirrhotic mice after BMC transplantation. We therefore initially resolved proteins extracted from serum samples at 48 h after BMC transplantation by 2-DE and compared spot intensity between control and BMC groups of mice. Six protein spots increased in the BMC group compared with the control group. MS revealed that these spots comprised apolipoprotein A1 (apoA1), apolipoprotein C3 (apoC3), vitamin D-binding protein, alpha-1-antitrypsin and proteasome subunit alpha type 1. We subsequently confirmed the levels of apoA1 in serum and liver samples by immunoblotting. ApoA1 increased at early stage (48 h and 1 wk) after BMC transplantation in this mouse model of liver cirrhosis. The early elevation of apoA1 might be useful to predict liver regeneration in cirrhotic mice after BMC transplantation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16548057     DOI: 10.1002/pmic.200500018

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  5 in total

Review 1.  Bone marrow cell-based regenerative therapy for liver cirrhosis.

Authors:  Takafumi Saito; Kyoko Tomita; Hiroaki Haga; Kazuo Okumoto; Yoshiyuki Ueno
Journal:  World J Methodol       Date:  2013-12-26

2.  Non-alcoholic fatty liver disease proteomics.

Authors:  Eva Rodríguez-Suárez; Antonio M Duce; Juan Caballería; Félix Martínez Arrieta; Estefanía Fernández; Carolina Gómara; Nere Alkorta; Usue Ariz; M Luz Martínez-Chantar; Shelly C Lu; Felix Elortza; José M Mato
Journal:  Proteomics Clin Appl       Date:  2010-02-03       Impact factor: 3.494

3.  Genomics and proteomics in liver fibrosis and cirrhosis.

Authors:  Rebekka A Hannivoort; Virginia Hernandez-Gea; Scott L Friedman
Journal:  Fibrogenesis Tissue Repair       Date:  2012-01-03

4.  Proteomic analysis of aqueous humor from patients with myopia.

Authors:  Xiaoming Duan; Qingjun Lu; Peng Xue; Hongjie Zhang; Zhe Dong; Fuquan Yang; Ningli Wang
Journal:  Mol Vis       Date:  2008-03-03       Impact factor: 2.367

5.  Serum proteomic predicts effectiveness and reveals potential biomarkers for complications in liver transplant patients.

Authors:  Wenjing Wang; Bo Wang; Chang Liu; Jing Yan; Xiaofan Xiong; Xiaofei Wang; Juan Yang; Bo Guo; Chen Huang
Journal:  Aging (Albany NY)       Date:  2020-06-12       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.